This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other lack of coordination
R18_OTHER_LACK_COORD
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
595 |
4. Check minimum number of eventsNone |
595 |
5. Include endpointsNone |
595 |
6. Filter based on genotype QC (FinnGen only) |
595 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R2[5-9]
- Name in latin
- Alia absentia coordinationis musculorum
Similar endpoints
↥List of similar endpoints to
Other lack of coordination
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the nervous and musculoskeletal systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 595 | 297 | 298 |
| Unadjusted period prevalence (%) | 0.12 | 0.10 | 0.13 |
| Median age at first event (years) | 59.16 | 55.24 | 63.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 535
- Matched controls
- 5348
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R27.0
ICD-10 Finland
Ataxia, unspecified
+∞
323.0
447
*
R27.8
ICD-10 Finland
Other and unspecified lack of coordination
+∞
101.3
94
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
90.8
83.2
91
12
TAB00
NOMESCO Finland
Lumbar puncture
17.3
62.2
101
71
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
165.4
57.1
59
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.4
45.9
118
196
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
251.1
45.7
46
*
AA1AD
NOMESCO Finland
CT of head and brain
4.1
42.4
207
710
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.0
35.8
107
214
R25.1
ICD-10 Finland
Tremor, unspecified
19.3
33.4
51
29
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
10.4
27.7
55
58
N03AE01
ATC
clonazepam; systemic
6.6
27.5
74
127
R42
ICD-10 Finland
Dizziness and giddiness
3.2
27.4
173
686
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.2
24.7
69
124
N99
ICPC
Neurological disease other
18.3
23.4
36
21
R26.0
ICD-10 Finland
Ataxic gait
87.3
22.9
25
*
N29
ICPC
Neurological sympt/complt other
12.7
21.9
39
33
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.4
21.7
59
102
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.8
21.4
75
176
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
21.3
54
85
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.5
20.1
48
69
G11.2
ICD-10 Finland
Late-onset cerebellar ataxia
+∞
19.9
19
*
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
25.7
19.7
27
11
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
109.1
19.7
21
*
R53
ICD-10 Finland
Malaise and fatigue
2.8
19.4
149
648
L28
ICPC
Limited function/disability (L)
3.0
18.7
123
485
N03AX12
ATC
gabapentin; oral
3.2
18.4
110
405
A28
ICPC
Limited function/disability NOS
3.0
18.1
117
455
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.1
17.6
72
196
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
17.1
189
997
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.4
16.8
86
282
G11.8
ICD-10 Finland
Other hereditary ataxias
+∞
16.8
16
*
SPAT1229
SPAT
Assessment of need for aid
3.8
16.4
73
214
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.6
16.3
35
43
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
49.1
16.1
19
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
20.0
15.7
23
12
R51.80
ICD-10 Finland
Headache
3.0
15.3
94
351
M03BX01
ATC
baclofen; systemic
10.2
14.9
29
30
R1250
NOMESCO Finland
Evaluation of functional capability
8.1
14.8
33
43
G35
ICD-10 Finland
Multiple sclerosis
13.1
14.5
25
20
SPAT1216
SPAT
Assessment of functional ability
2.7
14.3
108
457
R4120
NOMESCO Finland
Occupational therapy
3.8
14.0
60
170
N06AB04
ATC
citalopram; systemic
2.4
13.3
129
624
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
10.4
13.1
25
25
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.0
12.9
25
26
N28
ICPC
Limited function/disability (N)
7.8
12.8
29
39
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.5
12.8
62
195
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.7
12.6
57
169
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.6
12.6
44
103
A04
ICPC
Weakness/tiredness general
2.7
12.5
92
382
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.5
12.2
58
179
N06AX21
ATC
duloxetine; oral
3.1
12.2
71
255
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
12.2
78
298
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
12.0
106
489
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
11.9
165
936
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
10.9
11.9
22
21
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
11.8
112
534
R20.2
ICD-10 Finland
Paraesthesia of skin
3.8
11.8
50
141
R47.1
ICD-10 Finland
Dysarthria and anarthria
23.5
11.6
16
7
C07AA05
ATC
propranolol; systemic
2.4
11.6
110
523
R4110
NOMESCO Finland
Physiotherapy
2.1
11.5
167
965
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
+∞
11.5
11
*
7812A
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Abnormality of gait
+∞
11.5
11
*
G25.0
ICD-10 Finland
Essential tremor
7.1
11.3
27
40
R4130
NOMESCO Finland
Speech therapy
7.3
11.2
26
37
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.2
11.1
34
69
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.7
11.1
48
137
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
9.5
11.1
22
24
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.7
11.1
25
34
SPAT1234
SPAT
Support of social functional capacity
4.2
11.1
42
107
G72.9
ICD-10 Finland
Myopathy, unspecified
28.7
10.8
14
5
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
10.5
61
218
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
10.5
97
455
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.8
10.5
44
123
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
33.2
10.4
13
*
S06.0
ICD-10 Finland
Concussion
2.8
10.3
67
258
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.3
10.3
53
175
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
10.3
110
553
N03AX16
ATC
pregabalin; oral
2.1
10.2
136
754
M48.0
ICD-10 Finland
Spinal stenosis
2.5
10.0
79
341
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.5
10.0
25
40
N06AA09
ATC
amitriptyline; systemic
2.8
9.9
66
259
A01
ICPC
Pain general/multiple sites
3.1
9.8
55
192
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
13.7
9.7
16
12
N03AF01
ATC
carbamazepine; oral, rectal
3.6
9.6
42
122
R55
ICD-10 Finland
Syncope and collapse
2.6
9.6
71
296
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
+∞
9.4
9
*
N05BA04
ATC
oxazepam; oral
2.0
9.2
129
724
H53.2
ICD-10 Finland
Diplopia
4.7
9.1
30
67
N06AX11
ATC
mirtazapine; oral
1.9
9.0
166
1033
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
8.9
56
212
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.5
8.9
22
35
N03AX09
ATC
lamotrigine; oral
4.1
8.8
33
84
N18
ICPC
Paralysis/weakness
6.8
8.7
21
32
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
8.7
83
394
M54.5
ICD-10 Finland
Low back pain
1.9
8.7
163
1020
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.3
8.6
31
76
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
8.5
60
241
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
8.5
124
704
XKC03
NOMESCO Finland
Water cystometry
5.0
8.5
26
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
8.4
100
523
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
8.4
76
351
F44.4
ICD-10 Finland
Dissociative motor disorders
+∞
8.4
8
*
R27
ICD-10 Finland
Other lack of coordination
+∞
8.4
8
*
109
Kela drug reimbursment
Multiple sclerosis
11.0
8.3
15
14
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.9
8.3
51
188
Z31.5
ICD-10 Finland
Genetic counselling
3.7
8.2
35
100
R25.2
ICD-10 Finland
Cramp and spasm
7.7
8.2
18
24
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.6
8.2
36
106
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
7.0
8.1
19
28
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.9
8.0
25
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.0
159
1008
N02BE01
ATC
paracetamol; systemic, rectal
1.9
8.0
442
3821
N03AX14
ATC
levetiracetam; systemic
4.8
7.9
25
54
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.3
7.9
13
10
N19
ICPC
Speech disorder
8.6
7.9
16
19
NXL00
NOMESCO Finland
Biopsy of muscle
45.7
7.7
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.7
231
1661
SPAT1301
SPAT
No procedures
1.8
7.6
167
1090
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.2
7.6
14
14
M54.1
ICD-10 Finland
Radiculopathy
3.9
7.5
29
77
N03AG01
ATC
valproic acid; systemic, rectal
3.2
7.5
37
120
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
81.2
7.4
8
*
N05BA01
ATC
diazepam; systemic, rectal
2.2
7.4
77
380
AA1AA
NOMESCO Finland
Head X-ray examination
13.6
7.4
12
9
N17
ICPC
Vertigo/dizziness
2.3
7.4
67
309
N05AH04
ATC
quetiapine; oral
2.1
7.4
85
440
R11
ICD-10 Finland
Nausea and vomiting
2.7
7.3
50
198
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.7
7.2
46
177
G91.1
ICD-10 Finland
Obstructive hydrocephalus
20.3
7.2
10
5
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.1
7.1
37
125
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
7.1
49
197
N03AF02
ATC
oxcarbazepine; oral
4.1
7.1
26
66
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.4
7.0
24
57
N03AX11
ATC
topiramate; oral
5.3
7.0
20
39
G20
ICD-10 Finland
Parkinson disease
4.3
6.9
24
58
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
6.2
6.8
17
28
G81.9
ICD-10 Finland
Hemiplegia, unspecified
9.5
6.8
13
14
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.8
6.8
43
163
G24.9
ICD-10 Finland
Dystonia, unspecified
17.0
6.8
10
6
N04BC05
ATC
pramipexole; oral
2.7
6.7
43
165
G61.0
ICD-10 Finland
Guillain-Barré syndrome
22.8
6.7
9
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
4.3
6.7
23
55
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.7
65
311
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
6.7
50
211
SPAT1254
SPAT
Administration of medicine
2.0
6.7
88
482
WX892
NOMESCO Finland
Monitored bed care
2.6
6.6
46
185
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
6.6
87
472
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
12.4
6.6
11
9
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
12.4
6.6
11
9
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.6
143
925
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.4
70
352
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
6.4
76
395
R5110
SPAT
NA
4.5
6.4
21
48
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.3
6.4
56
256
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
8.3
6.4
13
16
G04BD07
ATC
tolterodine; oral
3.1
6.4
32
106
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.6
6.3
17
31
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
11.2
6.3
11
10
S01EC01
ATC
acetazolamide; systemic
4.4
6.3
21
49
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
6.3
40
152
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
18.3
6.3
9
5
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
18.3
6.3
9
5
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
18.3
6.3
9
5
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.3
212
1550
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
7.2
6.3
14
20
F80.1
ICD-10 Finland
Expressive language disorder
7.2
6.3
14
20
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
27.0
6.2
8
*
L03AX13
ATC
glatiramer acetate; parenteral
27.0
6.2
8
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.5
6.2
27
80
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
4.6
6.2
20
45
H81.3
ICD-10 Finland
Other peripheral vertigo
4.6
6.2
20
45
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
6.2
77
411
N06AX03
ATC
mianserin; oral
3.0
6.2
33
114
XCK00
NOMESCO Finland
Perimetry
2.6
6.2
43
173
N05CD07
ATC
temazepam; oral
2.1
6.1
72
373
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.1
89
502
N05CF01
ATC
zopiclone; oral
1.7
6.1
161
1102
Z50.5
ICD-10 Finland
Speech therapy
5.3
6.1
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
79
89
10.08
65.50
1.4
1.4
3.60
3.69
mmol/l
0.31
73
83
70
87
8.99
53.59
1.4
1.5
1138.13
1393.66
e6/l
0.07
60
71
70
87
8.99
53.59
1.4
1.4
6.93
14.35
e6/l
0.39
59
69
45
29
16.71
52.53
1.1
1.0
—
—
—
0
0
313
1408
3.58
51.72
2.5
2.1
209.27
266.70
u/l
0.39
302
1324
45
38
12.73
45.04
1.1
1.1
—
—
—
0
0
45
47
10.28
39.05
1.1
1.1
—
—
—
0
0
45
49
9.85
37.88
1.1
1.1
—
—
—
0
0
34
25
14.36
36.78
1.1
1.1
1.00
1.01
u/l
0.08
18
14
326
1923
2.54
27.22
2.2
2.0
91.92
93.32
pmol/l
0.23
181
995
88
287
3.42
22.30
1.4
1.3
—
43.65
—
0
15
104
376
3.14
22.27
1.8
3.4
66.82
66.39
g/l
0.21
95
341
361
2377
2.32
21.63
6.5
7.3
1.22
1.22
mmol/l
0.38
325
2004
128
534
2.78
21.10
1.9
1.8
1.71
1.52
%
1.50
112
462
335
2177
2.23
20.20
5.8
6.7
1.22
1.22
mmol/l
0.32
311
1963
22
21
10.84
20.11
1.2
1.2
—
—
—
0
0
18
14
13.23
18.62
1.2
1.4
230.15
81.28
nmol/l
—
13
9
24
8
31.18
18.46
1.2
1.1
16.34
17.93
umol/l
—
24
8
171
885
2.31
17.51
1.9
1.7
1093.15
1202.49
nmol/l
0.78
139
659
392
2819
2.14
16.97
5.2
5.0
6.53
6.71
mmol/l
0.95
375
2639
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
23
8.96
15.97
1.1
1.2
—
—
—
0
0
25
40
6.48
15.12
1.4
1.3
—
—
—
0
0
17
18
9.69
14.39
1.5
1.4
—
—
—
0
0
51
157
3.46
14.01
1.6
2.6
2.76
3.18
g/l
2.70
36
122
141
740
2.19
13.56
4.2
4.4
0.81
0.82
mmol/l
0.05
131
693
52
169
3.28
13.12
1.7
2.6
3.57
3.76
g/l
0.62
36
120
52
170
3.26
12.99
1.7
2.5
7.05
7.36
g/l
0.66
36
126
52
170
3.26
12.99
1.7
2.5
—
—
—
0
0
142
773
2.10
12.32
1.9
2.7
28.89
29.95
s
2.13
137
745
48
156
3.26
12.11
1.7
2.6
9.46
10.52
g/l
0.84
36
135
292
2039
1.85
12.05
6.5
5.0
35.50
35.41
g/l
0.10
280
1908
177
1051
1.97
12.04
1.3
1.3
1.57
1.33
u/ml
0.11
43
266
260
1766
1.84
11.61
4.2
3.3
—
—
—
0
0
186
1139
1.92
11.47
1.5
1.5
22.56
20.72
nmol/l
0.29
169
952
42
131
3.37
11.31
1.7
2.8
0.06
0.00
g/l
0.49
37
123
44
146
3.17
10.73
1.8
2.8
0.38
1.33
g/l
1.51
36
131
25
59
4.38
9.93
1.0
1.1
—
—
—
0
0
434
3542
1.83
9.65
4.5
4.1
12.37
12.10
mm/h
0.13
406
3251
222
1501
1.76
9.62
3.2
2.5
52.22
56.72
u/l
1.65
208
1398
449
3708
1.86
9.54
8.2
7.5
81.74
81.19
u/l
0.09
418
3476
136
792
1.93
9.53
1.8
1.8
—
—
—
0
0
37
120
3.22
9.38
1.8
2.9
0.00
0.00
g/l
0.00
32
114
330
2503
1.71
9.37
6.2
6.5
10.84
11.73
umol/l
0.58
318
2384
164
1020
1.84
9.36
2.9
2.6
6.93
5.84
e6/l
0.39
139
892
40
137
3.06
9.26
1.8
2.7
39.42
37.27
g/l
1.25
34
117
231
1594
1.73
9.23
3.0
3.5
2.35
2.35
mmol/l
0.06
198
1389
37
123
3.14
9.01
1.8
2.8
0.00
0.00
g/l
0.00
32
115
357
2796
1.69
8.74
8.6
9.2
4.21
4.12
e9/l
0.29
318
2449
309
2334
1.67
8.65
6.5
6.1
27.11
27.64
%
0.36
297
2176
305
2296
1.67
8.65
6.6
5.9
57.33
57.36
%
0.01
295
2158
15
26
5.89
8.36
1.2
1.0
256.17
235.86
ng/l
—
6
14
112
637
1.93
8.34
5.3
6.8
1.04
1.06
mmol/l
0.32
107
585
62
282
2.34
8.24
1.7
1.4
—
—
—
0
0
41
155
2.77
7.98
1.2
1.1
—
—
—
0
0
41
156
2.75
7.88
1.2
1.1
—
—
—
0
0
25
72
3.58
7.62
1.2
1.1
4.17
42.17
iu/ml
1.22
12
18
70
347
2.15
7.57
2.0
1.7
—
—
—
0
0
79
414
2.05
7.39
4.9
7.5
1.33
1.32
mmol/l
0.03
72
394
14
26
5.49
7.28
1.2
1.0
34.20
31.15
ng/l
—
5
13
14
26
5.49
7.28
1.2
1.0
1200.40
580.13
ng/l
—
5
15
12
19
6.43
7.27
1.8
2.1
2.38
1.86
umol/l
1.13
12
19
10
5
20.30
7.15
1.5
1.2
—
—
—
0
0
421
3534
1.65
7.08
4.2
3.8
14.95
14.82
pmol/l
0.48
384
3176
210
1494
1.63
7.05
4.0
3.4
20.28
113.21
e6/l
1.43
173
1155
15
31
4.94
6.96
1.2
1.2
—
—
—
0
0
170
1150
1.67
6.95
2.3
2.5
—
—
—
0
0
141
908
1.72
6.91
4.1
3.8
271.63
335.53
ng/l
0.13
112
737
94
536
1.90
6.89
1.6
1.8
—
—
—
0
0
16
36
4.54
6.74
1.2
1.2
—
94.40
—
0
5
193
1358
1.62
6.72
3.7
3.2
0.40
0.43
e6/l
0.10
158
1016
61
301
2.14
6.68
1.6
1.6
—
—
—
0
0
93
540
1.86
6.43
1.7
1.8
—
—
—
0
0
36
146
2.56
6.14
1.5
1.2
—
—
—
0
0
11
19
5.88
6.12
1.1
1.2
—
—
—
0
0
11
19
5.88
6.12
1.1
1.1
—
—
—
0
0
244
1850
1.54
6.01
4.7
3.6
59.56
43.02
ng/l
0.34
191
1299
89
521
1.83
5.99
4.5
8.6
4.98
5.11
kpa
0.61
83
496
10
16
6.34
5.97
1.1
1.1
—
—
—
0
0
26
90
2.98
5.96
1.2
1.2
—
—
—
0
0
89
522
1.83
5.95
4.5
8.6
11.84
11.96
kpa
0.07
83
499
65
345
1.99
5.87
3.2
5.7
0.55
1.66
mmol/l
1.96
51
266
11
20
5.58
5.82
1.1
1.2
—
—
—
0
0
11
20
5.58
5.82
1.1
1.3
—
—
—
0
0
11
20
5.58
5.82
1.1
1.3
—
—
—
0
0
372
3103
1.53
5.78
4.1
3.1
50.77
50.41
u/l
0.03
355
2898
250
1919
1.52
5.75
2.6
2.3
75.97
77.54
nmol/l
0.33
227
1697
88
521
1.81
5.71
4.5
8.7
1.05
1.29
mmol/l
0.23
66
414
25
87
2.96
5.69
1.2
1.4
—
—
—
0
0
25
87
2.96
5.69
1.2
1.4
—
—
—
0
0
12
25
4.88
5.51
1.1
1.0
—
—
—
0
0
145
996
1.60
5.42
1.7
1.7
443.36
11873139.45
pmol/l
0.79
123
817
32
131
2.52
5.38
1.6
2.0
—
—
—
0
0
75
432
1.84
5.31
2.6
2.2
377.63
371.44
nmol/l
0.09
70
401
149
1035
1.59
5.30
5.5
3.9
1.02
1.02
kg/l
0.33
27
148
122
807
1.64
5.30
3.4
3.1
4.15
2.10
e6/l
0.92
80
459
51
264
2.02
4.95
3.2
5.3
23.48
24.07
mmol/l
0.82
44
243
124
841
1.60
4.84
3.1
2.9
0.97
1.03
e6/l
0.11
82
486
12
28
4.35
4.84
1.0
1.0
—
—
—
0
0
99
635
1.67
4.83
11.6
24.6
1.15
1.33
inr
0.65
13
87
10
20
5.07
4.79
1.0
1.1
—
—
—
0
0
32
140
2.36
4.70
1.6
1.4
254.65
293.02
ug/g
0.44
20
79
78
473
1.75
4.66
4.0
4.6
1.48
1.80
mmol/l
0.36
62
377
78
476
1.74
4.56
2.3
2.5
0.20
0.21
g/l
0.44
72
444
13
34
3.89
4.55
1.3
2.4
—
—
—
0
0
203
1550
1.47
4.55
3.4
3.4
31.79
34.02
u/l
0.37
189
1476
105
696
1.62
4.49
2.1
2.5
2.32
2.32
g/l
0.01
97
649
64
370
1.82
4.49
2.9
4.3
73.41
80.86
ng/l
0.33
57
329
111
750
1.59
4.38
2.2
2.5
12.35
13.03
umol/l
0.41
105
698
9
12
7.60
4.36
1.0
1.4
—
—
—
0
0
8
9
8.99
4.29
1.1
1.0
—
—
—
0
0
8
9
8.99
4.29
1.1
1.0
—
—
—
0
0
7
6
11.78
4.28
1.1
1.0
—
—
—
0
0
124
865
1.55
4.26
3.4
3.1
2.46
2.45
mmol/l
0.19
102
771
167
1242
1.48
4.23
2.5
2.2
3.05
3.10
mg/l
0.10
153
1040
31
141
2.26
4.19
2.7
3.3
3.78
3.93
mmol/l
1.09
31
125
530
4922
1.70
4.02
24.2
16.7
139.36
139.68
mmol/l
1.73
522
4784
531
4935
1.71
4.00
24.4
16.8
3.98
3.98
mmol/l
0.09
523
4791
6
5
12.10
3.77
1.2
1.0
—
—
—
0
0
6
5
12.10
3.77
2.5
1.2
—
—
—
0
0
32
156
2.11
3.68
1.5
1.6
—
—
—
0
0
44
241
1.89
3.68
1.2
1.3
—
—
—
0
0
31
150
2.13
3.64
1.5
1.5
0.10
0.04
iu/ml
—
6
32
7
9
7.85
3.56
1.1
1.2
—
—
—
0
0
20
81
2.52
3.50
1.6
1.3
—
—
—
0
0
16
59
2.76
3.34
1.2
1.1
—
—
—
0
0
514
4788
1.54
3.26
21.7
14.3
25.08
24.49
mg/l
0.15
448
3791
472
4324
1.44
3.25
5.5
4.5
1.89
2.22
mu/l
0.62
447
3905
63
401
1.64
3.18
2.7
2.3
7.03
7.12
ug/l
0.01
56
348
18
73
2.51
3.15
1.9
1.5
—
—
—
0
0
6
8
7.56
3.06
2.3
2.1
19.98
16.66
umol/l
—
6
8
94
663
1.50
3.04
2.3
2.5
22.22
23.27
%
0.29
85
572
30
156
1.97
2.95
1.6
1.4
1.21
1.19
g/l
0.18
30
149
37
208
1.83
2.90
2.4
1.8
—
—
—
0
0
259
2190
1.32
2.84
3.5
4.2
—
—
—
0
0
5
6
8.39
2.75
1.4
6.3
—
—
—
0
0
19
388
0.47
2.74
1.4
1.7
—
—
—
0
0
28
147
1.95
2.70
1.7
1.4
0.21
0.23
g/l
1.05
28
142
106
785
1.43
2.67
1.3
1.3
24.77
38.95
iu/ml
0.87
26
241
7
15
4.71
2.60
1.1
1.1
—
—
—
0
0
12
44
2.76
2.56
1.0
1.1
—
—
—
0
0
136
1061
1.37
2.52
2.0
1.8
0.76
1.17
mg/l
3.17
102
811
80
568
1.47
2.52
10.2
6.7
—
—
—
0
0
241
2048
1.30
2.46
2.9
2.7
153.53
133.81
ug/l
0.39
226
1872
7
17
4.15
2.36
2.0
4.2
202.86
224.88
u/l
—
7
17
25
133
1.92
2.35
2.5
2.4
49.25
117.49
ug/min
1.23
16
78
39
239
1.68
2.32
5.7
10.5
24.73
24.61
mmol/l
0.08
34
221
14
59
2.41
2.31
1.4
1.6
—
—
—
0
0
22
117
1.91
2.09
1.1
1.1
—
—
—
0
0
261
2278
1.26
2.05
4.7
3.7
0.00
0.00
estimate
0.00
29
409
6
15
4.03
2.04
1.2
1.0
99.17
92.40
%
—
6
15
6
16
3.78
1.94
1.8
3.1
25.00
36.27
umol/l
—
6
11
31
190
1.67
1.88
2.4
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
145
1.76
1.84
2.1
6.2
0.40
0.31
u/ml
0.49
17
78
20
108
1.88
1.84
1.4
1.4
—
—
—
0
0
76
569
1.38
1.82
2.5
3.0
5.44
8.89
umol/l
2.19
64
502
5
12
4.19
1.82
1.2
1.1
—
—
—
0
0
21
117
1.82
1.76
1.3
1.3
—
—
—
0
0
7
25
2.82
1.65
1.6
1.3
—
—
—
0
0
7
25
2.82
1.65
1.6
1.3
—
—
—
0
0
257
2284
1.22
1.61
5.9
5.2
0.00
0.00
estimate
0.00
38
412
173
1476
1.24
1.60
4.3
3.1
6.78
7.64
mmol/l
2.11
146
1229
8
33
2.44
1.54
1.0
1.5
—
27.40
—
0
5
6
141
0.42
1.54
1.0
1.5
—
—
—
0
0
259
2312
1.21
1.53
4.7
3.8
0.00
0.01
estimate
0.50
35
399
7
27
2.61
1.52
1.6
1.3
—
—
—
0
0
7
27
2.61
1.52
1.6
1.3
—
—
—
0
0
7
28
2.52
1.45
2.0
1.8
—
—
—
0
0
167
1433
1.23
1.45
3.2
3.3
932.80
1469.03
ng/l
1.84
145
1224
146
1236
1.24
1.44
6.0
3.9
0.00
0.01
estimate
0.50
35
400
25
158
1.61
1.39
2.8
2.8
—
—
—
0
0
15
82
1.85
1.36
3.3
4.9
—
542.12
—
0
8
21
131
1.63
1.25
2.6
1.4
18.62
9.09
u/l
1.18
16
99
5
19
2.64
1.22
2.0
1.1
6.20
7.26
mmol/l
—
5
19
81
991
0.79
1.20
3.3
3.0
0.80
0.80
ug/l
0.01
60
655
11
57
1.95
1.17
1.4
1.2
—
—
—
0
0
75
603
1.28
1.16
4.4
4.4
32.74
31.87
%
0.28
62
391
20
126
1.61
1.16
1.2
1.7
—
—
—
0
0
5
20
2.51
1.15
1.0
1.6
—
—
—
0
0
5
20
2.51
1.15
1.0
1.6
—
—
—
0
0
524
5074
1.27
1.13
12.9
10.4
26.96
26.30
u/l
0.40
512
4894
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
5
22
2.28
1.03
1.2
1.7
1.52
1.21
nmol/l
—
5
14
12
68
1.78
1.01
1.5
1.4
—
—
—
0
0
32
232
1.40
0.99
1.1
1.0
—
—
—
0
0
5
23
2.18
0.98
1.0
1.4
—
—
—
0
0
12
69
1.75
0.97
1.6
1.4
—
—
—
0
0
12
69
1.75
0.97
1.6
1.4
—
—
—
0
0
9
51
1.78
0.95
1.0
1.7
—
—
—
0
0
154
1364
1.17
0.94
3.3
3.2
1870.77
213.62
mg/l
1.16
100
865
12
70
1.73
0.93
1.6
1.4
—
—
—
0
0
12
70
1.73
0.93
1.6
1.4
—
—
—
0
0
12
70
1.73
0.93
1.6
1.4
—
—
—
0
0
451
4328
1.17
0.92
6.5
5.8
40.18
40.03
mmol/mol
0.11
425
4008
88
743
1.22
0.91
1.4
1.3
3.21
11.33
u/ml
2.41
35
275
15
94
1.61
0.91
2.1
3.3
3.31
4.44
e9/l
2.76
15
94
462
4449
1.17
0.87
18.5
13.1
84.25
80.17
ml/min/173m2
3.39
397
3662
8
44
1.83
0.86
1.0
1.5
—
—
—
0
0
8
44
1.83
0.86
1.0
1.5
—
—
—
0
0
8
44
1.83
0.86
1.0
1.5
—
—
—
0
0
417
4344
0.87
0.86
21.2
15.7
39.29
39.66
%
0.37
283
3115
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
15
97
1.56
0.82
2.2
3.7
54.80
57.89
%
0.55
15
97
195
1778
1.14
0.81
5.2
3.9
—
—
—
0
0
9
147
0.61
0.80
1.9
1.9
—
—
—
0
0
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
474
4592
1.16
0.74
4.8
4.5
6.04
5.96
mmol/l
0.63
447
4166
13
84
1.56
0.72
1.2
1.5
—
—
—
0
0
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
5
26
1.93
0.70
1.0
1.5
—
—
—
0
0
15
101
1.50
0.70
6.5
7.2
1496.80
445.08
iu/ml
—
5
12
44
356
1.25
0.70
2.2
2.9
66.52
65.28
ml/min/173m2
0.07
23
148
13
85
1.54
0.69
2.1
1.6
—
—
—
0
0
446
4602
0.88
0.69
4.5
4.4
1.41
1.45
mmol/l
1.11
425
4208
159
1445
1.14
0.69
3.6
4.0
7.65
10.31
mg/mmol
0.53
101
919
7
42
1.67
0.68
1.9
2.7
—
—
—
0
0
7
42
1.67
0.68
1.1
1.0
—
—
—
0
0
430
4446
0.88
0.68
4.2
3.9
1.39
1.28
mmol/l
2.14
408
4054
11
70
1.58
0.65
1.2
1.2
—
—
—
0
0
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
0
21
0.00
0.60
0.0
3.2
—
—
—
0
0
451
4637
0.89
0.60
4.7
4.4
4.53
4.61
mmol/l
0.94
427
4263
0
23
0.00
0.58
0.0
5.4
—
37.00
—
0
6
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
10
66
1.52
0.53
1.3
1.5
—
—
—
0
0
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
30
243
1.25
0.50
4.1
3.2
1.26
1.21
%
0.11
30
243
7
45
1.56
0.49
2.1
2.4
—
—
—
0
0
539
5310
1.16
0.46
30.1
21.1
262.83
246.89
e9/l
5.73
530
5175
539
5313
1.15
0.44
30.3
21.1
4.42
4.49
e12/l
2.60
529
5167
15
113
1.34
0.43
1.0
1.7
—
—
—
0
0
539
5315
1.15
0.42
30.5
21.2
133.12
135.32
g/l
2.59
532
5229
8
56
1.43
0.42
1.1
1.2
—
—
—
0
0
284
2957
0.92
0.42
3.0
3.0
—
—
—
0
0
52
455
1.16
0.42
3.9
2.3
57.95
33.64
u/l
0.36
44
383
0
15
0.00
0.41
0.0
1.9
—
93.86
—
0
7
0
15
0.00
0.41
0.0
1.1
—
90.57
—
0
7
15
115
1.31
0.39
1.0
1.6
—
—
—
0
0
9
66
1.37
0.38
1.3
1.6
—
—
—
0
0
14
107
1.32
0.37
1.3
1.5
—
—
—
0
0
464
4727
0.92
0.36
5.2
4.9
2.68
2.73
mmol/l
0.51
435
4322
22
182
1.22
0.33
2.5
1.4
47.83
22.88
iu/l
1.66
16
146
18
146
1.24
0.32
1.4
1.3
—
—
—
0
0
16
128
1.26
0.32
1.4
1.4
—
—
—
0
0
129
1370
0.93
0.31
4.0
4.4
20.75
21.11
%
0.10
60
665
133
1256
1.08
0.29
2.8
2.7
4383.61
9038.24
umol/l
0.54
114
1088
11
85
1.30
0.28
1.0
1.6
—
—
—
0
0
57
623
0.91
0.27
1.3
1.4
—
—
—
0
0
5
71
0.70
0.26
1.6
2.9
105.80
105.58
mmol/l
—
5
71
9
74
1.22
0.25
2.2
2.4
1918.77
58.88
u/ml
—
9
69
5
38
1.32
0.23
4.0
2.5
532.00
590.27
ml
—
5
22
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
22.49
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
110.90
—
0
10
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
119
1246
0.94
0.20
1.6
1.7
1.39
1.36
mmol/l
0.13
107
1039
394
4000
0.96
0.19
24.8
17.6
13.89
13.70
%
1.12
388
3931
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
13
111
1.17
0.16
1.7
1.4
—
—
—
0
0
176
1710
1.04
0.15
5.0
5.1
2.59
2.67
ug/l
0.06
159
1524
10
119
0.84
0.15
2.1
1.5
—
—
—
0
0
38
406
0.93
0.12
2.0
2.0
—
—
—
0
0
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
15
136
1.11
0.08
1.9
1.6
—
—
—
0
0
6
57
1.05
0.08
1.5
1.6
—
—
—
0
0
7
83
0.84
0.07
1.4
1.2
7.69
37.90
u/l
—
7
72
79
811
0.97
0.07
1.6
1.5
—
—
—
0
0
9
105
0.85
0.06
1.3
1.4
—
—
—
0
0
47
487
0.96
0.06
3.2
3.3
—
—
—
0
0
15
140
1.07
0.04
1.3
1.6
43.00
41.23
nmol/l
0.12
15
132
11
119
0.92
0.04
1.0
1.3
—
—
—
0
0
23
222
1.04
0.02
2.6
1.8
—
—
—
0
0
13
124
1.05
0.00
1.2
1.4
—
—
—
0
0
18
174
1.04
0.00
1.9
1.8
—
—
—
0
0
29
296
0.98
0.00
1.2
1.2
222.91
152.67
iu/ml
0.26
11
106
51
515
0.99
0.00
2.8
4.2
15.76
36.02
ug/l
0.51
37
431
45
453
0.99
0.00
2.1
2.1
—
—
—
0
0
5
54
0.93
0.00
2.2
3.9
—
—
—
0
0
6
59
1.02
0.00
4.0
3.1
5.12
3.91
nmol/l
—
6
59
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
69
0.87
0.00
1.3
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
5
53
0.94
0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.06
—
0
5
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
0.00
1.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
0.00
1.1
1.1
1.84
1.45
g/l
—
8
73
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.5
—
79.29
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_OTHER_LACK_COORD – Other lack of coordination
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).